Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Kairos Ventures, a venture capital firm with ties to multiple academic institutions, hopes to raise $250m for its third main fund.

Plant-based burger manufacturer Impossible Foods is hoping to more than double its current valuation of $2bn, having already raised some $750m from investors including GV.

University of Arizona's tech transfer office generated 11 spinouts during the past financial year sealed 96 licence and option agreements.

Brii Biosciences was among the participants in a series A round for infectious disease drug developer AN2 and has secured Chinese commercialisation rights for the startup's lead asset.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis, Bayer, Evotec, Merck Group and Alexandria Real Estate Equities all invested in Longwood Fund-founded cancer immunotherapy startup Immunitas Therapeutics.

Reese Schroeder and Tom Mastrobuoni are reportedly looking to leave due to the unit's imminent move from Chicago to Arkansas.

Amperex, SDK, Cabot Corporation and BASF Venture Capital all invested, as the battery materials developer disclosed funding that will be used to beef up manufacturing.

The furniture rental platform has confirmed it recently raised series B funding from investors including WeWork, HNI and JLL Spark.